CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,250,247 | -18.9% | 380,591 | -12.7% | 1.16% | -50.1% |
| Q1 2023 | $4,005,921 | -49.7% | 435,900 | -44.1% | 2.33% | -41.9% |
| Q4 2022 | $7,963,800 | -34.0% | 780,000 | -4.9% | 4.01% | -44.6% |
| Q3 2022 | $12,070,000 | -31.8% | 820,000 | -50.3% | 7.24% | -40.4% |
| Q2 2022 | $17,698,000 | -27.2% | 1,649,400 | -26.9% | 12.14% | +53.7% |
| Q1 2022 | $24,309,000 | -50.7% | 2,255,000 | -25.3% | 7.90% | -5.5% |
| Q4 2021 | $49,286,000 | +8.7% | 3,020,000 | +42.6% | 8.35% | +18.9% |
| Q3 2021 | $45,336,000 | – | 2,117,500 | – | 7.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |